<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02836964</url>
  </required_header>
  <id_info>
    <org_study_id>5160039</org_study_id>
    <nct_id>NCT02836964</nct_id>
  </id_info>
  <brief_title>Early Loading of Dental Implants; A Prospective Study in the Mandibular First Molar Area.</brief_title>
  <official_title>Early Loading of Dental Implants; A Prospective Study in the Mandibular First</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the clinical success, stability, radiographic bone level changes and&#xD;
      peri-implants soft tissue parameter of the SLActive surface implant supporting single crowns&#xD;
      restorations in early loading in the mandibular first molar region.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The human clinical trial will be designed as a longitudinal prospective study. A total of 24&#xD;
      titanium implants with a modified SLA surface (BLT SLActive®, Institute Straumann AG, Basel,&#xD;
      Switzerland) will be placed in the mandibular first molar. 12 for the control group and for&#xD;
      the 12 test group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>marginal bone level changes by using periodical radiography.</measure>
    <time_frame>assessment of marginal bone level (MBL) will be made at the time of implant placement and after 6 months</time_frame>
    <description>Standardized radiographs using customized jig and long cone paralleling technique, using Rinn Film holders (Dentsply, Germany) for assessment of marginal bone level (MBL) will be made at the time of implant placement, as well as at 3 and 6 months 3. Changes in interproximal crestal bone levels will be measured and recorded using NIH Image Program Software(http:/rsb.info.nih.gov/nih-image)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Dental Implants</condition>
  <arm_group>
    <arm_group_label>Loading of Dental Implants after 4 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A total of 12 titanium implants with a modified SLA surface (BLT SLActive®, Institute Straumann AG, Basel, Switzerland) will be placed in the mandibular first molar. for this group.&#xD;
After 4 weeks definitive crown will be placed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Loading of Dental Implants after 3 months</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A total of 12 titanium implants with a modified SLA surface (BLT SLActive®, Institute Straumann AG, Basel, Switzerland) will be placed in the mandibular first molar for this group. After 3 months definitive crown will be placed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dental Implant</intervention_name>
    <description>Dental implant</description>
    <arm_group_label>Loading of Dental Implants after 3 months</arm_group_label>
    <arm_group_label>Loading of Dental Implants after 4 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients aged 18 years or older.&#xD;
&#xD;
          2. Willingness to comply with all study requirements.&#xD;
&#xD;
          3. Partially edentulous in the in mandibular first molar with presence of the mandibular&#xD;
             second molar&#xD;
&#xD;
          4. Patients of ASA I and ASA II group. No relevant medical conditions such as&#xD;
             uncontrolled diabetes mellitus, osteoporosis, malignancies, irradiation and blood&#xD;
             dyscrasias.&#xD;
&#xD;
          5. Free from soft tissue mucosal lesions, caries, and active periodontitis at the time of&#xD;
             implant insertion.&#xD;
&#xD;
          6. Sufficient alveolar bone volume at the implant recipient site at the time of the&#xD;
             insertion.&#xD;
&#xD;
          7. Adequate oral hygiene. Full-mouth plaque score (FMPS) (O'Leary et al. 1972) full-mouth&#xD;
             bleeding score (FMBS) (Ainamo &amp; Bay 1975) record as the percentage of surfaces, four&#xD;
             per each tooth, patients need to have controlled their periodontal conditions (FMPS&#xD;
             20%, FMBS 20%).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or lactating females.&#xD;
&#xD;
          2. Systemic disease likely to compromise implant surgery; uncontrolled diabetes mellitus.&#xD;
&#xD;
          3. History of irradiation in the head and neck area.&#xD;
&#xD;
          4. Smoking.&#xD;
&#xD;
          5. Untreated periodontitis.&#xD;
&#xD;
          6. Alcohol or drug abuse.&#xD;
&#xD;
          7. History of Intravenous Bisphosphonate.&#xD;
&#xD;
          8. Previously augmented or tooth extraction at the intended implant recipient site within&#xD;
             the last 6 months.&#xD;
&#xD;
          9. The use of regenerative procedures in conjunction with implant placement.&#xD;
&#xD;
         10. Presence of residual roots at the implant recipient site.&#xD;
&#xD;
         11. Stomatological diseases.&#xD;
&#xD;
         12. Clinical signs of bruxism.&#xD;
&#xD;
         13. Initial stability at least 35Ncm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aladdin j Alardah, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>associate professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bader s albader, DDS</last_name>
    <phone>9095584983</phone>
    <phone_ext>0000</phone_ext>
    <email>balbader@llu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Loma Linda Health</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2016</study_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Aladdin Al-Ardah, DDS, MS</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>December 27, 2019</submitted>
    <returned>January 10, 2020</returned>
    <submitted>June 14, 2021</submitted>
    <submission_canceled>June 14, 2021</submission_canceled>
    <submitted>August 18, 2021</submitted>
    <returned>September 15, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

